A Combined Risk Score Model to Assess Prognostic Value in Patients with Soft Tissue Sarcomas.
Zihua LiZhengwei DuanKeyao JiaYiwen YaoKaiyuan LiuYue QiaoQiuming GaoYunfeng YangGuodong LiAnquan ShangPublished in: Cells (2022)
The interaction between cuproptosis and immunity in sarcoma may provide a novel insight into the study of molecular mechanisms and candidate biomarkers for the prognosis, resulting in effective treatments for sarcoma patients.